Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Pietrantonio
HER2 Loss in HER2-positive Gastric or Gastroesophageal Cancer After Trastuzumab Therapy: Implication for Further Clinical Research
International Journal of Cancer
Cancer Research
Oncology
Related publications
Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer
Scientific Reports
Multidisciplinary
Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine
Medicine
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine
Cancer Management and Research
Oncology
Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines
BMC Health Services Research
Health Policy
Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
Dynamic Changes in CD44v-positive Cells After Preoperative Anti-Her2 Therapy and Its Correlation With Pathologic Complete Response in HER2-positive Breast Cancer
Oncotarget
Oncology
